Skip to main content

Tag: Systems Pharmacology

Certara Announces New COVID-19 Biosimulation Platform and Key Updates to Its Quantitative Systems Pharmacology (QSP) Technology Platforms

By

Major platform advancements demonstrate applicability of biosimulation to accelerate drug discovery and development PRINCETON, NJ – Aug 10, 2020 – Certara®, the global leader in biosimulation, today announced the development of a new biosimulation platform for COVID-19 vaccines and major enhancements in its Immunogenicity and Immuno-oncology QSP platforms.  Certara has partnered with leading, global pharmaceutical … Continued

Salvaging CNS Clinical Trials Halted Due to COVID‐19

By

The coronavirus disease 2019 (COVID‐19) pandemic has halted many ongoing central nervous system (CNS) clinical trials, especially in Alzheimer’s disease. These long‐duration trials involve many stakeholders, especially the patients and their family members, who have demonstrated their commitment to developing new therapeutic interventions for this devastating disease. We certainly do not want to lose all … Continued

Certara Expands Its Quantitative Systems Pharmacology Group; Appoints Professor Andrzej Kierzek

By

PRINCETON, NJ – Feb. 3, 2016 – Certara®, the global biosimulation technology-enabled drug development company, today announced that it has appointed Andrzej Kierzek, PhD, as head of systems modeling in its Simcyp® Quantitative Systems Pharmacology (QSP) Group. He joins Certara from the University of Surrey, UK, where he serves as professor of systems biology. Certara … Continued

Certara Appoints Prof. Piet van der Graaf to Lead New Quantitative Systems Pharmacology Organization

By

PRINCETON, NJ – Dec. 1, 2015 – Certara®, the global biosimulation technology-enabled drug development company, today announced that it has appointed Professor Piet van der Graaf, PharmD, PhD, as its vice president of quantitative systems pharmacology (QSP) and the head of its new Simcyp® QSP organization. Van der Graaf is professor of systems pharmacology, chair … Continued

Certara Acquires Quantitative Systems Pharmacology Consultancy, XenologiQ

By

PRINCETON, NJ – Dec. 1, 2015 – Certara®, the global biosimulation technology-enabled drug development company, today announced that it has acquired XenologiQ, a UK-based quantitative systems pharmacology (QSP) consultancy. “This transaction strengthens Certara’s modeling and simulation capabilities, increases its leadership in mechanistic pharmacology, and supports the company’s precision medicine vision,” said Certara Chief Executive Officer … Continued

2 of 2